Skip to main content
TELA Bio, Inc. logo

TELA Bio, Inc. — Investor Relations & Filings

Ticker · TELA ISIN · US8723811084 US Manufacturing
Filings indexed 494 across all filing types
Latest filing 2026-04-30 Annual Report
Country US United States of America
Listing US TELA

About TELA Bio, Inc.

https://www.telabio.com/

TELA Bio, Inc. is a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions. The company designs, develops, and markets a portfolio of products engineered to leverage a patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. Its core product line, the OviTex® Reinforced Tissue Matrix, combines layers of ovine (sheep) rumen with interwoven polymer sutures. This technology is designed to offer strength and facilitate tissue remodeling with a lower foreign body footprint than traditional synthetic mesh. TELA Bio's products are used in a variety of surgical procedures, including hernia repair, abdominal wall reconstruction, and plastic and reconstructive surgery.

Recent filings

Filing Released Lang Actions
ARS - TELA Bio, Inc. (0001561921) (Filer)
Annual Report
2026-04-30 English
S-8 - TELA Bio, Inc. (0001561921) (Filer)
Regulatory Filings
2026-03-25 English
8-K - TELA Bio, Inc. (0001561921) (Filer)
Regulatory Filings
2026-03-20 English
4 - TELA BIO, INC. (0001561921) (Filer)
Director's Dealing
2026-02-25 English
4 - TELA BIO, INC. (0001561921) (Filer)
Director's Dealing
2026-02-25 English
4 - TELA BIO, INC. (0001561921) (Filer)
Director's Dealing
2026-02-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.